Chi‐Yuan Wu

Metabolism and Disposition of Dasatinib after Oral Administration to Humans

Lisa J. Christopher, Donghui Cui, Chi‐Yuan Wu et al. · Drug Metabolism and Disposition · 2008 · 197 citations

Medicine, Pharmacokinetics, Pharmacology +13

A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis

Gerd R Burmester, Iain B. McInnes, Joel M. Kremer et al. · Annals of the Rheumatic Diseases · 2017 · 126 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Ex Situ Inhibition of Hepatic Uptake and Efflux Significantly Changes Metabolism: Hepatic Enzyme-Transporter Interplay

Yvonne Lau, Chi‐Yuan Wu, Hideaki Okochi et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 107 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase I Study of U3-1287, a Fully Human Anti-HER3 Monoclonal Antibody, in Patients with Advanced Solid Tumors

Patricia LoRusso, Pasi A. Jänne, Moacyr Oliveira et al. · Clinical Cancer Research · 2013 · 91 citations

Medicine, Oncology, Pharmacology +17

DISPOSITION OF TACROLIMUS IN ISOLATED PERFUSED RAT LIVER: INFLUENCE OF TROLEANDOMYCIN, CYCLOSPORINE, AND GG918

Chi‐Yuan Wu, Leslie Z. Benet · Drug Metabolism and Disposition · 2003 · 62 citations

Pharmacy, Pharmacokinetics, Pharmacology +17